Daphne B. Stewart, M.D.
- Associate Clinical Professor, Department of Medical Oncology & Therapeutics Research
- Medical Oncologist
Daphne B. Stewart, M.D.
- Medical Oncology
Daphne Stewart, M.D., is an Associate Clinical Professor in the Department of Medical Oncology & Therapeutics Research at City of Hope's South Pasadena and Antelope Valley locations. Dr. Stewart joined City of Hope from the David Geffen School of Medicine at UCLA, where she was an Associate Clinical Professor of Clinical Medicine, as well as the Associate Program Director for the Olive View-UCLA and Cedars Sinai Hematology-Oncology Fellowship. Prior to this, from 2005 to 2008, she was Associate Director for Cedars Sinai Medical Center's Blood and Marrow Transplant Program.
Dr. Stewart received her undergraduate degree with honors from the University of California at Berkeley. She went on to earn her medical doctorate, graduating with honors (Alpha Omega Alpha) from Columbia University's College of Physicians and Surgeons in New York City, and later received a Masters degree in biomathematics and clinical research from UCLA. She completed an internship in internal medicine at UCLA's Center for Health Sciences, and then went on to complete a hematology-oncology fellowship at UCLA's David Geffen School of Medicine, where she was a Specialty Training and Advanced Research (STAR) fellow.
Dr. Stewart is board certified in hematology, medical oncology and internal medicine, and is an accomplished and experienced clinician, clinical researcher and a committed teacher, with expertise in both hematology and medical oncology. She has a particular interest in coagulation and she has published six articles in the peer-reviewed literature, two review articles, three chapters and seven abstracts.
- 2013-present, Associate Clinical Professor and Staff Physician, Department of Medical Oncology & Therapeutics Research, City of Hope, South Pasadena, CA
- 2011-2013, Associate Program Director, Olive View-UCLA and Cedars Sinai Hematology-Oncology Fellowship, Olive View-UCLA Medical Center, Los Angeles, CA
- 2008-2013, Physician Specialist Hematologist-Oncologist, Department of Medicine, Division of Hematology-Oncology, Olive View-UCLA Medical Center, Los Angeles, CA
- 2005-2008, Associate Director, Blood and Marrow Transplant Program, Cedars Sinai Medical Center, Los Angeles, CA
- 1998, M.D., Columbia University, College of Physicians and Surgeons, New York, NY
- 1993, B.A., English, with honors, University of California, Berkeley, CA
- 2005, Fellowship: Hematology-Oncology, David Geffen School of Medicine, UCLA, Los Angeles, CA
- 2002, Residency in Internal Medicine, UCLA, Center for Health Sciences, Los Angeles, CA
- 2000, Internship in Internal Medicine, UCLA, Center for Health Sciences, Los Angeles, CA
- 1999, Internship in Obstetrics and Gynecology, Los Angeles County-USC Medical Center, Los Angeles, CA
- Medical Oncology
- Internal Medicine
- Jahan R, Stewart D, Vintners J, Yong W, Vinuela F, Vandenber P, Marder VJ. "Middle cerebral artery occlusion in the rabbit using selective angiography. Application for assessment of thrombolysis." Stroke. 2008; 39(5):1613-1615.
- Stewart D, Marder VJ, Starkman S, Saver J. "Magnesium sulfate neither potentiates nor inhibits tissue plasminogen activator-induced clot lysis." Journal of Thrombosis and Hemostasis. 2006; 4(7): 1575-1579
- Stewart D, Kong M, Novokhatny V, Jesmok G, Marder VJ. "Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage." Blood. 2003; 101(8): 3002-3007
- Sadeghi S, Marder VJ, Stewart D, Kong M, Humphries J, Baumbach G, Jesmok G. "Safety of plasmin in the setting of concomitant aspirin and heparin administration in a rabbit model of bleeding." Journal of Thrombosis and Hemostasis. 2003; 1(12): 2621-2625.
- Haramaki N, Stewart D, Packer L. "Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion." Free Radical Biology in Medicine. 1998; 25(3): 329-339.
- Haramaki N, Stewart D, Aggarwal S, Kawabata T, Packer L. "Role of ascorbate in protection by nitecapone against cardiac reperfusion injury." Biochemical Pharmacology. 1995; 50(6): 839-843.